Biosciences, Biotechnology
Greek researchers from FORTH, NKUA and Harvard University reveal a new mechanism that regulates intestinal stem cells
In an article published recently at the high-impact journal Nature Communications, researchers from NKUA, FORTH-IMBB, and Harvard University, led by Prof. Aristides Eliopoulos of NKUA and postdoctoral researcher Dr. Zoe Veneti of FORTH-IMBB, reveal a new mechanism that regulates the proliferation and differentiation of intestinal stem cells.
Prestigious ERC Consolidator Grant awarded to FORTH Researcher Dr. Panagiotis N. Moschou
Panagiotis N. Moschou, Researcher at the Institute of Molecular Biology and Biotechnology (IMBB) of the Foundation for Research and Technology – Hellas (FORTH) and Associate Professor at the Department of Biology, University of Crete is awarded a Consolidator Grant from the European Research Council (ERC).
New study reveals the mechanisms that drive neural tumour progression to malignancy
A new research study FORTH-IMBB, published in the international peer reviewed science journal PNAS, reveals how cancer cell intrinsic mechanisms and interactions with the microenvironment shape brain tumour growth and progression to malignancy.
New study reveals a key role of mRNA metabolism determinants in ageing and disease, through the regulation of mitochondrial biogenesis and function
The new findings highlight the importance of mRNA storage and degradation, near mitochondria, as a mechanism for maintaining cellular and organismal homeostasis
FORTH researcher, Prof. Electra Gizeli, new elected member of the European Organization for Molecular Biology (EMBO)
This international distinction is awarded based on outstanding contribution to science and advancement of life sciences, through high-level innovative research and achievements.
A pivotal International Neuroscience Conference hosted in Crete
The prestigious International Neuroscience Conference of the European Molecular Biology Organization (EMBO), entitled "Cell Biology of the Nervous System", was held at the Fodele Beach Hotel, in Crete, from 8 to 11 May 2023.
Prestigious HFSP Research Grant awarded to FORTH Researcher Dr. Anastasios Pavlopoulos
Anastasios Pavlopoulos, Principal Researcher at the Institute of Molecular Biology and Biotechnology of the Foundation for Research and Technology – Hellas (IMBB-FORTH) is awarded a Research Grant from the 2023 Human Frontiers Science Program. HFSP promotes international collaboration in basic research focused on the elucidation of the sophisticated and complex mechanisms of living organisms.
FORTH’s Researchers a step closer to unraveling the secrets of the brain function - Featured in Nature Communications Editors' Highlights
In a recent publication, featured in the prestigious scientific journal Nature Communications Editors' highlights, the team of Dr. Panayiota Poirazi, Research Director at ΙΜΒΒ, presents a new software framework that allows the incorporation of dendrites and their key mechanisms into large-scale neural network models.
IMBB scientists uncovered a novel cellular mechanism that regulates ageing and fertility
Research at the Institute of Molecular Biology and Biotechnology of FORTH published in the premier international scientific journal Nature Aging, reveals a fundamental quality control mechanism that operates in cells to safeguard the integrity and function of the nucleus. By maintaining nuclear homeostasis, this molecular mechanism contributes critically to promote longevity and fertility. IMBB researchers Dr. Margarita-Elena Papandreou and Dr. Georgios Konstantinidis, headed by Dr. Nektarios Tavernarakis (Professor at the Medical School, University of Crete, and Chairman of the Board at FORTH), discovered that recycling of nuclear and nucleolar components via autophagy delays ageing of somatic cells, and sustains the immortality of germ cells, which are required for reproduction.
Can the three-dimensional organization of the T cell genome regulate (auto)immunity?
The research team's next step, in the field of autoimmunity research, involves the design of highly specific small molecules to be tested for their ability to inhibit inflammation and autoimmunity, initially in a mouse model and later in humans.
Page:123 | Next >